Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase

Peptides

Volumn 27, Issue 11, 2006, Pages 2846-2857

  Chai, Biaoxin ^a   Li, Ji Yao ^a   Zhang, Weizhen ^a   Newman, Erika ^a   Ammori, John ^a   Mulholland, Michael W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; GT1 1 cells; Melanocortin 4 receptor; Mitogen activated protein kinase; NDP MSH

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA INTERMEDIN DERIVATIVE; CASPASE 3; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA FRAGMENT; GONADORELIN; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL IMMORTALIZATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GONADORELIN RELEASE; HYPOTHALAMUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; HUMANS; HYPOTHALAMUS; MAP KINASE SIGNALING SYSTEM; MICE; NEURONS; RECEPTOR, MELANOCORTIN, TYPE 4; SIGNAL TRANSDUCTION;

EID: 33750042605     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.05.005     Document Type: Article

References (49)

1. Adan R.A., Cone R.D., Burbach J.P., and Gispen W.H. Differential effects of melanocortin peptides on neural melanocortin receptors. Mol Pharmacol 46 (1994) 1182-1190
2. Bohm M., Wolff I., Scholzen T.E., Robinson S.J., Healy E., Luger T.A., et al. Alpha-melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280 (2005) 5795-5802
3. Caruso C., Mohn C., Karara A.L., Rettori V., Watanobe H., Schioth H.B., et al. Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 79 (2004) 278-286
4. Cepoi D., Phillips T., Cismowski M., Goodfellow V.S., Ling N., Cone R.D., et al. Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis. Brain Res 1000 (2004) 64-71
5. Chai B.X., Neubig R.R., Millhauser G.L., Thompson D.A., Jackson P.J., Barsh G.S., et al. Inverse agonist activity of agouti and agouti-related protein. Peptides 24 (2003) 603-609
6. Chai B.X., Pogozheva I.D., Lai Y.M., Li J.Y., Neubig R.R., Mosberg H.I., et al. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors. Biochemistry 44 (2005) 3418-3431
7. Daniels D., Patten C.S., Roth J.D., Yee D.K., and Fluharty S.J. Melanocortin receptor signaling through mitogen-activated protein kinase in vitro and in rat hypothalamus. Brain Res 986 (2003) 1-911
8. Eichholtz T., de Bont D.B., de Widt J., Liskamp R.M., and Ploegh H.L. A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J Biol Chem 268 (1993) 1982-1986
9. Ellacott K.L., and Cone R.D. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog Horm Res 59 (2004) 395-408
10. Elliott R.J., Szabo M., Wagner M.J., Kemp E.H., MacNeil S., and Haycock J.W. Alpha-melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol 122 (2004) 1010-1019
11. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., and Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome [see comment]. Nature 385 (1997) 165-168
12. Funabashi T., and Kimura F. The number of luteinizing hormone-releasing hormone immunoreactive neurons is significantly decreased in the forebrain of old-aged female rats. Neurosci Lett 189 (1995) 85-88
13. Gantz I., and Fong T.M. The melanocortin system. Am J Physiol: Endocrinol Metab 284 (2003) E468-E474
14. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268 (1993) 15174-15179
15. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C.J., and Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 200 (1994) 1214-1220
16. Griffon N., Mignon V., Facchinetti P., Diaz J., Schwartz J.C., and Sokoloff P. Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem Biophys Res Commun 200 (1994) 1007-1014
17. Grill H.J., Ginsberg A.B., Seeley R.J., and Kaplan J.M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J Neurosci 18 (1998) 10128-10135
18. Huang Q., and Tatro J.B. Alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1beta gene expression following transient cerebral ischemia in mice. Neurosci Lett 334 (2002) 186-190
19. Huh S.K., Lipton J.M., and Batjer H.H. The protective effects of alpha-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery 40 (1997) 132-139 (discussion, 139-40)
20. Jabbour H.N., Kelly R.W., and Boddy S.C. Autocrine/paracrine regulation of apoptosis in epithelial cells by prostaglandin E2. Prostagl Leukotrienes Essential Fatty Acids 67 (2002) 357-363
21. Kadekaro A.L., Kavanagh R., Kanto H., Terzieva S., Hauser J., Kobayashi N., et al. Alpha-melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 65 (2005) 4292-4299
22. Khong K., Kurtz S.E., Sykes R.L., and Cone R.D. Expression of functional melanocortin-4 receptor in the hypothalamic GT1-1 cell line. Neuroendocrinology 74 (2001) 193-201
23. Le W.W., Wise P.M., Murphy A.Z., Coolen L.M., and Hoffman G.E. Parallel declines in Fos activation of the medial anteroventral periventricular nucleus and LHRH neurons in middle-aged rats. Endocrinology 142 (2001) 4976-4982
24. Liebmann C. Regulation of MAP kinase activity by peptide receptor signaling pathway: paradigms of multiplicity. Cell Signal 13 (2001) 777-785
25. Lin S.Y., Cui H., Yusta B., and Belsham D.D. IGF-I signaling prevents dehydroepiandrosterone (DHEA)-induced apoptosis in hypothalamic neurons. Mol Cell Endocrinol 214 (2004) 127-135
26. Lipton J.M., Macaluso A., Hiltz M.E., and Catania A. Central administration of the peptide alpha-MSH inhibits inflammation in the skin. Peptides 12 (1991) 795-798
27. MacNeil D.J., Howard A.D., Guan X., Fong T.M., Nargund R.P., Bednarek M.A., et al. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur J Pharmacol 450 (2002) 93-109
28. Mandrika I., Muceniece R., and Wikberg J.E. Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem Pharmacol 61 (2001) 613-621
29. Mellon P.L., Windle J.J., Goldsmith P.C., Padula C.A., Roberts J.L., and Weiner R.I. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5 (1990) 1-10
30. Milhavet O., McMahon H.E., Rachidi W., Nishida N., Katamine S., Mange A., et al. Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA 97 (2000) 13937-13942
31. Mountjoy K.G., Kong P.L., Taylor J.A., Willard D.H., and Wilkison W.O. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol Genomics 5 (2001) 11-19
32. Moustafa M., Szabo M., Ghanem G.E., Morandini R., Kemp E.H., MacNeil S., et al. Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Invest Dermatol 119 (2002) 1244-1253
33. Sachs C.W., Safa A.R., Harrison S.D., and Fine R.L. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. J Biol Chem 270 (1995) 26639-26648
34. Schatzl H.M., Laszlo L., Holtzman D.M., Tatzelt J., DeArmond S.J., Weiner R.I., et al. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 71 (1997) 8821-8831
35. Schwartz G.K., Haimovitz-Friedman A., Dhupar S.K., Ehleiter D., Maslak P., Lai L., et al. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. J Natl Cancer Inst 87 (1995) 1394-1399
36. Seeley R.J., Drazen D.L., and Clegg D.J. The critical role of the melanocortin system in the control of energy balance. Annu Rev Nutr 24 (2004) 133-149
37. Sommer U., Costello C.E., Hayes G.R., Beach D.H., Gilbert R.O., Lucas J.J., et al. Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells. J Biol Chem 280 (2005) 23853-23860
38. Sortino M.A., Condorelli F., Vancheri C., and Canonico P.L. Tumor necrosis factor-alpha induces apoptosis in immortalized hypothalamic neurons: involvement of ceramide-generating pathways. Endocrinology 140 (1999) 4841-4849
39. Spulber S., Moldovan M., Oprica M., Aronsson A.F., Post C., Winblad B., et al. Alpha-MSH decreases core and brain temperature during global cerebral ischemia in rats. Neuroreport 16 (2005) 69-72
40. Sugden P.H., and Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 9 (1997) 337-351
41. Teare K.A., Pearson R.G., Shakesheff K.M., and Haycock J.W. Alpha-MSH inhibits inflammatory signalling in Schwann cells. Neuroreport 15 (2004) 493-498
42. Teare K.A., Pearson R.G., Shakesheff K.M., Raisman G., and Haycock J.W. Alpha-MSH inhibits inflammatory signalling in olfactory ensheathing cells. Neuroreport 14 (2003) 2171-2175
43. Vaisse C., Clement K., Durand E., Hercberg S., Guy-Grand B., and Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity [see comment]. J Clin Invest 106 (2000) 253-262
44. Van der Ploeg L.H., Martin W.J., Howard A.D., Nargund R.P., Austin C.P., Guan X., et al. A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci USA 99 (2002) 11381-11386
45. Vongs A., Lynn N.M., and Rosenblum C.I. Activation of MAP kinase by MC4-R through PI3 kinase. Regul Pept 120 (2004) 113-118
46. Wardlaw S.L. Clinical review 127: obesity as a neuroendocrine disease: lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. J Clin Endocrinol Metab 86 (2001) 1442-1446
47. Wetsel W.C., Mellon P.L., Weiner R.I., and Negro-Vilar A. Metabolism of pro-luteinizing hormone-releasing hormone in immortalized hypothalamic neurons. Endocrinology 129 (1991) 1584-1595
48. Zemel M.B., and Shi H. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity. Nutr Rev 58 (2000) 177-180
49. Zhong Q., Sridhar S., Ruan L., Ding K.H., Xie D., Insogna K., et al. Multiple melanocortin receptors are expressed in bone cells. Bone 36 (2005) 820-831